{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:21:51Z","timestamp":1707524511293},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,22]]},"DOI":"10.7759\/cureus.24373","type":"journal-article","created":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T14:00:36Z","timestamp":1650636036000},"source":"Crossref","is-referenced-by-count":0,"title":["Intrapleural Tissue Plasminogen Activator and Dornase Alfa Administration for a Multiloculated Recurrent Malignant Pleural Effusion: A Case Report"],"prefix":"10.7759","author":[{"given":"Kia","family":"Nikoomanesh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander T","family":"Phan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veerpal","family":"Sond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mufadda","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0019-2016","article-title":"Malignant pleural effusion: from bench to bedside","volume":"25","author":"Psallidas I","year":"2016","unstructured":"Psallidas I, Kalomenidis I, Porcel JM, Robinson BW, Stathopoulos GT. Malignant pleural effusion: from bench to bedside. Eur Respir Rev. 2016, 25:189-98. 10.1183\/16000617.0019-2016","journal-title":"Eur Respir Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2017.07.79","article-title":"Diagnosis and management of malignant pleural effusions: state of the art in 2017","volume":"9","author":"Desai NR","year":"2017","unstructured":"Desai NR, Lee HJ. Diagnosis and management of malignant pleural effusions: state of the art in 2017. J Thorac Dis. 2017, 9:1111-22. 10.21037\/jtd.2017.07.79","journal-title":"J Thorac Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201807-1415ST","article-title":"Management of malignant pleural effusions. An official ATS\/STS\/STR clinical practice guideline","volume":"198","author":"Feller-Kopman DJ","year":"2018","unstructured":"Feller-Kopman DJ, Reddy CB, DeCamp MM, et al.. Management of malignant pleural effusions. An official ATS\/STS\/STR clinical practice guideline. Am J Respir Crit Care Med. 2018, 198:839-49. 10.1164\/rccm.201807-1415ST","journal-title":"Am J Respir Crit Care Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/LBR.0000000000000265","article-title":"Intrapleural fibrinolytic therapy in patients with nondraining indwelling pleural catheters","volume":"23","author":"Vial MR","year":"2016","unstructured":"Vial MR, Ost DE, Eapen GA, Jimenez CA, Morice RC, O'Connell O, Grosu HB. Intrapleural fibrinolytic therapy in patients with nondraining indwelling pleural catheters. J Bronchology Interv Pulmonol. 2016, 23:98-105. 10.1097\/LBR.0000000000000265","journal-title":"J Bronchology Interv Pulmonol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/rcr2.457","article-title":"Very low-dose intrapleural tPA for indwelling pleural catheter-associated symptomatic fluid loculation","volume":"7","author":"Lan NS","year":"2019","unstructured":"Lan NS, Vekaria S, Sidhu C, Lee YC. Very low-dose intrapleural tPA for indwelling pleural catheter-associated symptomatic fluid loculation. Respirol Case Rep. 2019, 7:e00457. 10.1002\/rcr2.457","journal-title":"Respirol Case Rep"},{"key":"ref6","article-title":"Intrapleural instillation of tPA and DNase for symptomatic loculated malignant pleural effusion. B45. Pleural disease: clinical studies","volume":"195","author":"Rivera-Flores E","year":"2017","unstructured":"Rivera-Flores E, Kheir F, Bussy SF, Parikh M, Majid A. Intrapleural instillation of tPA and DNase for symptomatic loculated malignant pleural effusion. B45. Pleural disease: clinical studies. Am J Respir Crit Care Med. 2017, 195:A3553.","journal-title":"Am J Respir Crit Care Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2008.01276.x","article-title":"Pleural fluid viscosity may help identifying malignant pleural effusions","volume":"13","author":"Chang LC","year":"2008","unstructured":"Chang LC, Hua CC, Liu YC, Chu CM, Chen HJ, Lee N. Pleural fluid viscosity may help identifying malignant pleural effusions. Respirology. 2008, 13:341-5. 10.1111\/j.1440-1843.2008.01276.x","journal-title":"Respirology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/MAJ.0b013e318123eead","article-title":"Repeated thoracenteses affect proinflammatory cytokines, vascular endothelial growth factor, and fibrinolytic activity in pleural transudates","volume":"334","author":"Chung CL","year":"2007","unstructured":"Chung CL, Yeh CY, Sheu JR, Chen YC, Chang SC. Repeated thoracenteses affect proinflammatory cytokines, vascular endothelial growth factor, and fibrinolytic activity in pleural transudates. Am J Med Sci. 2007, 334:452-7. 10.1097\/MAJ.0b013e318123eead","journal-title":"Am J Med Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1012740","article-title":"Intrapleural use of tissue plasminogen activator and DNase in pleural infection","volume":"365","author":"Rahman NM","year":"2011","unstructured":"Rahman NM, Maskell NA, West A, et al.. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med. 2011, 365:518-26. 10.1056\/NEJMoa1012740","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201704-0809OC","article-title":"Randomized controlled trial of urokinase versus placebo for nondraining malignant pleural effusion","volume":"197","author":"Mishra EK","year":"2018","unstructured":"Mishra EK, Clive AO, Wills GH, et al.. Randomized controlled trial of urokinase versus placebo for nondraining malignant pleural effusion. Am J Respir Crit Care Med. 2018, 197:502-8. 10.1164\/rccm.201704-0809OC","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/92237-intrapleural-tissue-plasminogen-activator-and-dornase-alfa-administration-for-a-multiloculated-recurrent-malignant-pleural-effusion-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:45:20Z","timestamp":1707507920000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/92237-intrapleural-tissue-plasminogen-activator-and-dornase-alfa-administration-for-a-multiloculated-recurrent-malignant-pleural-effusion-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,22]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.24373","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,22]]}}}